Innoviva (INVA)

• Market cap: $1.71B
• 1 day: 0.52%
• 5 days: -3.43%
• 1 month: -1.28%
• 3 months: 10.15%
• 6 months: 27.61%
• Year to date: 16.31%
• 1 year: 23.91%
• 5 years: 98.37%
• 10 years: 92.42%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Employees: 159